Localisation of Secretory Leucocyte Proteinase Inhibitor mRNA in Nasal Mucosa
Authors:
Ulla Westin a;
Ulla Fryksmark a;
sa Polling b;
Kjell Ohlsson b
sa Polling b;
Kjell Ohlsson b
| Affiliations: | a Department of Otolaryngology and Head and Neck Surgery, Malm General Hospital, University of Lund, Sweden |
b Department of Surgical Pathophysiology, Malm General Hospital, University of Lund, Sweden |
DOI:
10.3109/00016489409126042
Publication Frequency:
12 issues per year
Subject:
Otorhinolaryngology;
Formats available:
PDF
(English)
View Article:
View Article (PDF)
Abstract
Human secretory leucocyte proteinase inhibitor (SLPI) is a low-molecular weight, acid-stable inhibitor of polymorphnuclear granulocyte elastase and cathepsin G. Previous reports have demonstrated the existence of SLPI in the respiratory tract, salivary glands and cervical mucosa. Positive staining for SLPI using immunohistochemical techniques has been reported in serous glands in nasal mucosa. We now confirm this observation and show, using in situ hybridization, that the pattern of expression of mRNA corresponds to the distribution of the encoded protein, SLPI. This, together with the high concentration of SLPI in nasal secretions, confirms the hypothesis of a local production of SLPI in the mucous membranes.
|
| Keywords: SLPI; protease inhibitor; mRNA; serous glands; nasal mucosa |
| view references (18) |


Download Citation
General Hospital, University of Lund, Sweden
CiteULike
Del.icio.us
BibSonomy
Connotea